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Abstract: Theoretical and experimental evidences support the hypothesis that the genomes and the epigenomes may be 
different in the somatic cells of complex organisms. In the genome, the differences range from single base substitutions to 
chromosome number; in the epigenome, they entail multiple postsynthetic modifications of the chromatin. Somatic ge-
nome variations (SGV) may accumulate during development in response both to genetic programs, which may differ 
from tissue to tissue, and to environmental stimuli, which are often undetected and generally irreproducible. SGV may 
jeopardize physiological cellular functions, but also create novel coding and regulatory sequences, to be exposed to in-
traorganismal Darwinian selection. Genomes acknowledged as comparatively poor in genes, such as humans’, could thus 
increase their pristine informational endowment. A better understanding of SGV will contribute to basic issues such as the 
“nature vs nurture” dualism and the inheritance of acquired characters. On the applied side, they may explain the low yield 
of cloning via somatic cell nuclear transfer, provide clues to some of the problems associated with transdifferentiation, 
and interfere with individual DNA analysis. SGV may be unique in the different cells types and in the different develop-
mental stages, and thus explain the several hundred gaps persisting in the human genomes “completed” so far. They may 
compound the variations associated to our epigenomes and make of each of us an “(epi)genomic” mosaic. An ensuing 
paradigm is the possibility that a single genome (the ephemeral one assembled at fertilization) has the capacity to generate 
several different brains in response to different environments. 
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“Where will genomics be ten years from now? As sequencing capacity increases globally and the data quality improves, we 
will move beyond the current goal of one genome per person by sequencing multiple genomes per person… The genomic 
revolution is just beginning.” (J. C. Venter, Nature 464:676-677, 2010). 
INTRODUCTION 
  It is known that the famous physicist Erwin Schrödinger, 
Nobelist in 1933 “for the discovery of new productive forms 
of atomic theory”, pioneered the advent of molecular biology 
with a widely quoted booklet [1] which stimulated many 
colleagues of different expertise to converge on the study of 
DNA. Less known is a statement where Schrödinger seren-
dipitously anticipated a violation of a tenet to be formulated 
after the unveiling of the DNA double helix. In particular 
Schrödinger stated: “…all the cells of our body are exactly 
identical for what pertains their chromosomes”,  and in a 
footnote added: “But biologists will forgive me if I do not 
mention the exceptional cases of mosaics”. It is probable that 
the “mosaics” alluded to here were the products of intrauter-
ine exchanges of embryonic cells between fraternal twins.  
  The tenet at risk of violation descended directly from the 
“central dogma of molecular biology”, promulgated in the 
early 1950s by Francis Crick, codiscoverer of the double 
helix and admittedly one of the many physicists converted to 
molecular biology by Schrödinger. Crick’s dogma prescribed  
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that in living cells the genetic information flows from DNA 
to RNA and hence to proteins, but not backwards; in the 
1970s it had to be revised because of the discovery of re-
verse transcription of RNA into DNA. But by and large the 
dogma still stands as a cornerstone of the biosciences, espe-
cially with regard to the logically consequent invariability 
(a.k.a. continuity or stability) of the somatic genomes. A 
significant statement has appeared recently in a Nature 
commentary [2]: “Whereas the hard-wired genome is virtu-
ally identical in all of a person's roughly 250 different types 
of tissue and is essentially stable during that person's life-
time, the epigenome changes during development such that 
each cell type has its own characteristic set of marks. These 
marks change with age and may also change, possibly in a 
heritable way, in response to environmental stress”.  
  It is also known that epigenomics studies the complex but 
reversible modifications of chromatin (i. e., DNA plus the 
wealth of accompanying proteins and non-coding small 
RNA) [3], whereas genomics addresses the base sequences 
of the DNA present in the living cells. But if it is question-
able that epigenomic marks are “directly dependent” on 
DNA sequence, as Ptashne et al. state in a recent note to Na-
ture [4], the two are not unrelated: “In contrast to the DNA 
sequence which is identical in all tissues, the patterns of 
chromatin modifications and DNA methylation are tissue 
specific. Thus our genome contains two layers of informa-380    Current Genomics, 2010, Vol. 11, No. 6  Astolfi et al. 
tion: the DNA sequence inherited by our parents which is 
fixed throughout life and identical to most extent in all the 
cells and tissues of our body, and chromatin and methylation 
patterns which are cell and tissue specific. It is clear that 
gene function and thus the phenotype could be influenced not 
only by the gene sequence but also by the epigenetic pro-
gramming of the sequence.” [5]. Even more explicitly it has 
been stated that: “The proper development of multicellular 
organisms entails the distinct specification of disparate cell 
types. Despite having identical genomic sequences, different 
cell types exhibit substantially different profiles of gene ex-
pression, and their cellular identity must be conserved dur-
ing somatic cell divisions. How then are cell-specific gene-
expression patterns specified and maintained? It is now rec-
ognized that the key is ‘epigenetics’: the stable and heritable 
information that is distinct from DNA sequences and fostered 
by specialized mechanisms.” [6].  
  We propose here that there is a third layer of informa-
tion, represented by the variations affecting the somatic ge-
nomes throughout development: the ensuing genomic mo-
saicism responds not only to epigenetic fluctuations often 
traceable to the environment [5-8], but also to genetic deter-
minism, hence to both chance and necessity. For the transac-
tions affecting DNA sequences we suggest the expression 
Somatic Genome Variations (or SGV), as preferable to the 
common Copy Number Variations (CNV), given that, e. g., 
non-replicative transpositions and inversions are not stricto 
sensu CNV. 
  At present SGV are perceived no longer as syndromic to 
disease, but also as marks of differentiation. The acceptance 
of their existence, and even of their importance, has gone 
through the stepwise and haphazard additions of bits of evi-
dence, but is steadily consolidating. The picture has been 
aptly summarized as follows: “Fortunately, in the face of 
ever-increasing level of variation being discovered in the 
human genome, there is at least one touchstone: the genomes 
of all the cells in a cancer-free individual are the same. 
However, even in this bedrock, a few cracks have appeared. 
For example, it is well-known that immune cells undergo 
rearrangements and deletions at immunoglobulin loci. Cases 
are also known of genomic mosaicism, even as far as ane-
uploidy in sub-population of cells […]. But, aside from these 
peculiar exceptions, and barring mutations accumulated as 
part of the ageing process, the genomes in all of your cells 
are identical. Or are they?” [9]. In order to help answering 
this rhetorical question we must critically review the main 
notions supporting the invariability of the somatic genome: 
they include the extraordinary accuracy recognized to in vi-
tro DNA replication, the stability of DNA borne by somatic 
and germinal nuclei, the constancy of the 2:1 ratio of their 
respective masses, the persistence of familiar traits through 
different generations. The seal to these notions was provided 
in the early 1960s by cloning via somatic cell nuclear trans-
fer (SCNT) in amphibians: their main finding was that the 
somatic nuclei transferred into enucleated unfertilized or 
fertilized oocytes could produce healthy organisms; their 
main conclusion was that such nuclei should be considered 
totipotent. But those experiments had at least three caveats: 
(a) only embryonic and fetal cells would provide functional 
nuclei; those from adult cells would fail, at least in those 
early days; (b) yields have since remained close to  1% of 
transferred nuclei, essentially regardless of their donor cells; 
(c) the resulting totipotence does not necessarily imply full 
identity of the involved genomes, as shown by the few 
clones grown to adulthood, which were taken as genotypi-
cally “identical” to the nuclei donors, but resulted  pheno-
typically different, at least health-wise.  
 But  the  rhetorical question raised above by Dear [9] co-
gently underscores the complexities of the SGV issue. The 
debate over the invariability of the somatic genome is more 
than a century old: for a review see, e. g., [10]. At the begin-
ning it was thought that multicellular organisms would de-
velop their manifold traits either through a differentially 
regulated expression of a constant genome (Delage, Spe-
mann and others), or alternatively through genomic struc-
tural variations which would lead to different patterns of 
gene expression (Driesch, Weismann and others). Mutations 
were thought to occur in single cells, where they would dis-
rupt gene structure and function, and thus occasionally trig-
ger dramatic genomic alterations, uncontrolled growth of 
clonal progeny cells into anomalous and eventually diseased 
tissues  [11]. Shortly, the notion of the variation of the so-
matic genome could be accepted, as long as it was associated 
to pathology. That under normal conditions all the somatic 
cells of an organism would harbor the same genome had 
become almost a second dogma: it predicated its invariability 
in the somatic cells of any complex organism throughout, 
and in spite of, its differentiation and development. But its 
tenet had to coexist with some contrasting evidences:  
  (a) in living cells the genetic information flows also from 
RNA back to DNA, and does so both spatially (i.e., in differ-
ent cells), and temporally (i.e., at different developmental 
stages): the apostle of this tenet was Howard Temin, who 
studied RNA viruses and stated that “This normal process of 
information transfer in cells could not exist only for its abil-
ity to give rise to viruses. It must exist as a result of its role 
in normal cellular processes, for example cell differentia-
tion, antibody formation and memory” [12]; remarkable pre-
diction indeed, especially for what concerns memory and 
more in general cognitive functions. But still not enough to 
secure an official imprimatur to Temin’s doctrine even long 
after the subsequent extensive characterization of retrovi-
ruses [13] and in general of retroelements [14];  
  (b) the eukaryotic genomes host a variety of transposable 
elements (TE), at least in part responsible for improving the 
response of the organisms to the environment; the apostle of 
this tenet was Barbara McClintock, who clearly summarized 
her ideas as follows: “I believe that there is little reason to 
question the presence of innate systems that are able to re- 
structure a genome. It is now necessary to learn of these 
systems and to determine why many of them are quiescent 
and remain so over long periods of time, only to be triggered 
into action by forms of stress, the consequences of which 
vary according to the nature of the challenges to be met. In 
addition to modifying gene action, these elements can re- 
structure the genome at various levels, from small changes, 
involving a few nucleotides, to gross modifications, involving 
large segments of chromosomes, duplications, deficiencies, 
inversions and other more complex reorganizations.”  [15] 
Both Temin and McClintock were eventually awarded fully 
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while to accept their teachings, and hesitate to recognize that 
the integration of DNA copies of RNA sequences into the 
nuclear genome, as well as the chromosomal vagaries of TE, 
are incompatible with the stability of the somatic genomes 
and must lead to their restructuring.  
  Probably easier to be accepted are the concepts put for-
ward by Zeh et al. [16] with regard to the causative relation-
ship of epigenetics with regard to transpositions especially in 
evolution:  “According to the “epi-transposon hypothesis”, 
physiological stress, associated with major climatic change 
or invasion of new habitats, disrupt epigenetic silencing, 
resulting in TE reactivation, increased TE expression and/or 
germ-line infection by exogenous retroviruses. Mobilized TE 
rapidly restructure the genome and alter gene expression 
patterns…”. However their correlations to development are 
steadily emerging, as revealed by the following quotations 
from Kazazian and Ostertag [17]: “Time and further re-
search will tell whether McClintock’s hypothesis that TE 
have a significant role in an organism’s development can be 
extended from maize to humans, and specifically to the func-
tions of human neurons.”. Discussing nervous system disor-
ders, Lee & Lupski [18] display a more open view and hy-
pothesize that “gene copy number variations due to struc-
tural alteration may be responsible for both normal and ab-
normal behavioral phenotypes”. 
  Many other instances of intraindividual somatic genome 
variations can be predicted at the theoretical level; several 
have indeed been described and they do not necessarily vio-
late consolidated enunciations, since they act through re-
combination and similar notorious and legitimate transac-
tions. But apart from mechanisms, their impact on the con-
cept that all our cells harbour the same genome may threaten 
the central dogma and question some extant major projects. 
STATE OF THE ART 
  It is still accepted that at each cellular division the struc-
ture of the genome as assembled at fertilization is faithfully 
duplicated together with the rest of the cell [6], apart from 
epigenetic changes and occasional ploidy variations [19]. In 
this way the genetic information is transmitted essentially 
unchanged to all the cells of our developing body, in its ger-
minal as well as somatic lineages. Thus the phenotypes of 
the organism were seen as the gradual decoding of the in-
formation carried by a constant genome and expressed in the 
many features proper of our ~250 kinds of tissues, with all 
the subroutines of sophisticated programs of gene activa-
tion/inactivation. In cells where changes are the rule, one 
notable exception would therefore stand out: the genome, 
admittedly a fundamental element of our soma. Thus, 
throughout development the genome would remain un-
changed. But several documented objections are raised 
against this view: they provide support to frequent, different 
and substantial manifestations of SGV, which go from single 
base substitutions or modifications to chromosome-scale 
events and may differ from traditional mutations since they 
are at least partly programmed. Some of the relevant objec-
tions to the invariability of the genome stem out of theoreti-
cal considerations: take, e. g., the genome huge size (in terms 
of bp man has ~6.10
9) which makes it an easy target for 
damages (~10
4 per cell per day according to Jackson & 
Bartek [20]) , the number of cells contributing to the steady 
state of a human organism (~10
14), the high number of mito-
ses (~10
16) necessary for the organism’s full maturation and 
susceptible to errors and mishaps. Apart from these quantita-
tive data, in the genome we have an extraordinary abundance 
of all sorts of transposable/unstable sequences, often exceed-
ing 50% of the total DNA [16], and a reasonable confidence 
that most of these considerations apply to both animals [21] 
and plants [22]. Finally, there is the paradox of the low num-
ber of the human coding genes, 22,287 as acknowledged in 
2006 by the Ensemble 34rd Catalogue of the IHGSC, as such 
close to those of a nematode [23] and to one third of a protist 
[24]; it cannot be excluded that such a gene paucity could be 
partially compensated through the intervention of SGV.  
  The strength of all these arguments contrasts with the 
weakness of the extant experimental data: beyond the classi-
cal cases of the gene reorganization controlling the immune 
response in vertebrates, of the macro/micro-nuclei transac-
tions in protozoa, and of the telomere attritions punctuating 
the development of most eukaryotes, reports detailing tissue-
specific and age-related variations in the genomes of eukary-
otic cells are preciously few [24, 25].  
  Many recent data are, however, coalescing and paving 
the way to a desirable and feasible experimental characteri-
zation of SGV. One is the reported low success rate of clon-
ing  via SCNT, which is more compatible with rearrange-
ments suffered by the relevant somatic cells genomes [26], 
than with technical hurdles [27]. Suggestive indications can 
be excerpted from recent genomic data: thus, the similarity 
of the estimated numbers of SGV in a given genome and of 
the gaps persisting in the sequences of the “quasi-completed” 
genomes available thus far [28, 29] point to an involvement 
of SGV. When the genomes of a mixture of cells of the same 
lineage of the same individual are being sequenced, at the 
SGV sites their genomes are likely to host heterogeneous 
sequences typical, or even unique, of each cell under study. 
It is in fact possible that some cells could bear alterations 
which result from untemplated, error-prone DNA repair at 
the sites of their occurrence, as in the assembly of the immu-
noglobulins and related genes. The genomic revolution [30], 
the unpredicted discoveries of systems similar to myelomas 
and the zooming on some of the most obvious of such sites 
will help to clarify the issue in the future. Advancements are 
expected from the increasingly powerful “next generation” 
sequencing tools. Discussing the interesting discovery that 
the jawless sea lamprey Petromyzon marinus looses close to 
20% of their somatic genome during development, Eichler 
and colleagues underline the programmed nature of their loss 
which includes at least one transcribed gene, and conclude: 
“Thus, the loss of DNA could result in the generation of cod-
ing, promoter, enhancer, etc. sequences that impart unique 
functionality to somatic cell lineages.” [31]. 
  As to their insurgence mechanisms, SGV may be trig-
gered by genetic programs responding also to external stim-
uli/stresses [8, 32, 33], DNA replication/repair errors [34], 
exposure to variably processed reverse transcripts of viral 
genomes [35] and of pseudogenes [36], horizontal gene 
transfers [37], etc. In some cases the environmental circum-
stances may elicit a programmed cellular death (apoptosis). 
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events  via gene copy number variations, TE repositioning 
and representation, expansion or contraction of repeats (long 
or short, tandem or dispersed), chromosomal aberrations. 
Ultimate measures may be the loss of entire chromosomes 
and eventually the elimination of the whole nucleus, as in 
mammalian erythrocytes. All, nota bene, under the aegis of a 
rigorous somatic Darwinian selection.  
  Within the same organism different cell lineages, and 
possibly within the same lineages, single cells may display 
peculiar instances of SGV. Remarkably, cleavage stage hu-
man embryos are reported to suffer sudden dramatic insur-
gence of severe complex chromosomal aberrations, admit-
tedly absent in the participating gametes [38, 39; see also the 
accompanying contribution of Robberecht et al. in this issue] 
and eventually responsible of undetected abortions of zy-
gote-derived structures [40]; later on, the emerging germ 
lines may enjoy a peculiar protection against the insurgence 
of SGV as compared to the rest of the soma. Conversely, a 
preferential susceptibility to SGV may be found associated 
with cells positioned next to the boundary between environ-
ment and organism and progressing to a postmitotic stage, 
such as functional neurons [41, 42]. It has been proposed that 
the ensuing DNA rearrangements tend to occur close to the 
chromosomal sites involved in segmental duplications and to 
act as hotspots for further rearrangements and recombina-
tions [43]. The genomic alterations caused by SGV may in-
volve up to ~20% of the human genome [44]. This may af-
fect many functions and support an inordinately increase in 
their frequency and size throughout development and aging 
[45]. An important message emerging from these data is that 
SGV may feature in supposedly “normal” cells and not only 
represent symptoms of extant or incumbent disease, from 
cancer to severe neurodegenerative disorders like Alz-
heimer’s disease and ataxia telangiectasia [46]. This last con-
sideration gains credibility thanks to the blurred demarcation 
between physiology and pathology, ostensibly occurring in 
derangements of the immune system [47] and, probably, of 
the nervous system [40]. 
  By altering the organization of the genome of affected 
cells, and hence their coding capacity as well as their regula-
tion, SGV may account for a good share of the organismal 
phenotypic differences. This hypothesis is becoming attrac-
tive and in the last few years SGV have been enlisted within 
the traditional elements concurring to the shaping of the 
phenotype: these include the zygotic genome, as assembled 
at fertilization; the environment, in its macro-components, 
surrounding the whole organism as it develops, as well as its 
micro-components, surrounding each cell; and the epige-
nome,  i. e., the sum of the transient, inducible and partly 
inheritable modifications of the chromatin of the cells. These 
concepts have been elaborated in a graphical representation 
for which the term “ontogenic pyramid” has been proposed 
(Fig. 1), to suggest an idea and a model that in due course 
will probably undergo stringent criticism and re-elaboration.  
  A productive experimental effort aimed to the characteri-
zation of SGV must first detail out a broad strategic plan and 
then an accurate description of the operations in term of ma-
terials and methods. The optimal experimental organism(s) 
should display several useful traits, such as a complex devel-
opmental program leading to lineages as differentiated as 
possible; representative cells should derive from tissues 
originating from each of the three layers of an animal gas-
trula or from plant embryo structures; cells easy to be iso-
lated as pure and uncontaminated as possible would be pref-
erable; a reliable “reference” genome should be available for 
comparing the changes emerging during development. A 
reasonable prediction as to which sequences may be more 
amenable to SGV could first consider (retro)transposons, 
then elements such as LINEs and SINEs, especially those 
sequences known or suspected to assume anomalous non-B 
conformations [44, 48]. It has been reported that, in the spec-
trum of the events responsible for human genome variations, 
deletions are more frequent than insertions or other rear-
rangements [49]: this is reasonable and may reflect a com-
pensatory removal of sequences following synthetic 
(retro)transpositions otherwise responsible of an unbearable 
overgrowth of the genome size [50]. Relevant to this is the 
observation that during development: “The set of genes de-
leted is not random in the (human) genome; there is a clear 
association with segmental duplications among larger dele-
tion events. In addition to previously reported associations 
with immunity, defence, chemosensation and drug detoxifica-
tion, other functional gene categories emerge in these stud-
ies, such as signal transduction, sex hormone metabolism 
and cancer susceptibility.” [51]. Somehow ironically, indi-
cations for cells more susceptible to SGV may turn out to be 
a major contribution to science of the once much hyped or-
ganismal cloning: the finding that animal tissues (e. g., neu-
rons) are more recalcitrant than others (e. g., cumulus) at 
producing mouse clones via SCNT could betray some tissue 
specificity of SGV [26, 52, 53] rather than technical hurdles. 
A second criterion for spotting cells more prone to SGV and 
thus more useful for their characterization, could be the ex-
tent of their epigenetic modifications: these changes control 
the structure of chromatin, and hence possibly vary the se-
quence of its DNA. This may occur through transcription, 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). The “ontogenic pyramid”. The phenotype (PHE) may be 
seen as the result of four variables: the original zygotic genome 
(GEN), the environments (ENV), the epigenome (EPI) and the 
somatic genome variations (SGV). The two headed arrows are 
meant to suggest complex reciprocal interactions between them. 
From Sgaramella & Astolfi [39], with permission. Are we Genomic Mosaics?  Current Genomics, 2010, Vol. 11, No. 6    383 
then reverse transcription of some resulting RNA followed 
by the genomic integrations of their retrotranscripts as retro-
posons and pseudogenes [5, 16, 35, 54]. 
  In a concerted approach to the study of SGV particular 
attention may go to: (1) their manifold nature, (2) their time-
course during growth, (3) their molecular mechanisms, (4) 
their significance vis-à-vis the physiological as well as the 
pathological development of the organism, (5) their rele-
vance on applied science as it regards, e. g., reproductive and 
regenerative cloning, induction of pluripotency, DNA analy-
sis, etc. 
  It would be desirable to focus on plant and animal mod-
els, better if endowed with relatively short life spans: this 
would facilitate the monitoring of the time course of SGV 
from early developmental stages to senescence and death. 
Among plants, a suitable system may be represented by A. 
thaliana [55], whereas among animals mice may be prefer-
able, in spite of the somehow lower fraction of repeats in 
their genome [56]. Needless to say that humans are the ulti-
mate objective. 
  From a practical viewpoint, it would be proper to study 
SGV in as few cells as possible, given the peculiar, if not the 
unique, nature of SGV. Single cell genome analysis would 
be highly desirable and may be reached in a not too distant 
future [57]. 
  The study of SGV rests heavily on the use of efficient 
sequencing technologies [26], to be applied to whole ge-
nomes, or to parts selected because of their higher predispo-
sition to SGV, as based either on prior knowledge, e. g., 
retroposons, as discussed by Sen et al. [58], or on acquired 
experimental evidence (e. g., gene duplication sites), as dis-
cussed by Rohlin et al. [30], and by many others [59-62]. 
Possible concomitant epigenetic changes are expected to 
augment the complexities of the experimental approaches to 
SGV characterization. 
  In a note appeared almost five years after the first “com-
pletion” of the Human Genome Project it was remarked that 
“Uncovering the genetic basis of human phenotypic differ-
ences requires a comprehensive understanding of all forms 
of genetic variation”, and the following explicit conclusions 
were reached: “First, no single optimized approach has been 
developed yet to systematically capture all structural varia-
tion in the human genome. Second, it is likely that several 
thousand additional common structural variants await dis-
covery. Their abundance, enrichment in environmental-
interaction genes and their apparent attributes in terms of 
natural selection suggest that these genetic lesions will be 
important in genetic disease. A more systematic, unbiased 
approach to discover and genotype such variation is re-
quired. A Human Genome Structural Variation Project dedi-
cated to the characterization of not only deletions but also of 
insertions and inversions should become a priority for the 
human genetics and human genome sequencing communities 
in an effort to further widen the spectrum of human genetic 
variation” [51]. The relevance of these remarks has only 
been increasing in these last few years. If we were to place 
the adjective “somatic” before the substantives “genetics” 
and “genome”, as they recur in Eichler’s note, and to use the 
prefix “(epi-)” ahead of both of them, and if we were to en-
large the scope of his exhortations beyond disease to normal 
human traits, we would find a close match to the subject and 
the scope of this paper.  
CONCLUSIONS 
  In shaping the physical, behavioural and cognitive human 
phenotypes, nature and nurture cooperate, probably not as 
independent entities. Rather they interact in a complex man-
ner: accordingly, the genotype, the environmental stresses 
and/or stimuli, the epigenome [8] and finally SGV talk to 
each other so that eventually the genomes of any somatic 
cells may end up as unique patchworks and as such differ not 
only from the ephemeral genome of the zygote, but also 
among its many tissutal or even cellular versions [7, 43].  
  In a sense we are what we are because of our genes, but 
our genes are what they are because their roles are played in 
different macro- and micro-environments. Both the genes we 
inherit and the environments we are placed in result from 
random samplings out of countless alternatives. The dialogue 
between genes and environment dictates the necessity of our 
genetic/genomic mosaicism, its augmentation during devel-
opment, its derangement during disease, possibly of its exal-
tation in forging our mind. Such interactions remind some of 
the ideas Lamarck published in 1809, the same year of Dar-
win's birth [63]. This underscores the desirability of an 
analysis of the genome and the epigenome of different cell 
lineages at different developmental stages, and, possibly, at 
the single cell level, if we want to understand reliably the 
biologic determination of what we are genomically and epi-
genomically at any given point of our life. In this regard, 
somehow similarly to their colleagues physicists who in the 
last century integrated Heisenberg’s “indetermination princi-
ple” in the characterization of the nuclear elementary parti-
cles, today geneticists may be advised to consider an “inde-
terminability” of the genotype-phenotype relationship, given 
the ever-changing nature of both partners [23, 43, 64]. If all 
this is confirmed, when facing the ancient dilemma concern-
ing the interactions of nature vs nurture in shaping our traits, 
we may find that the limits of the definition of the multifari-
ous contributions of nurture (i. e., diet, education, conscious 
and subconscious stresses and/or stimuli, etc) are no less 
severe than the contributions of nature (i. e., our many possi-
ble genomes), as recently discussed by several authors [32, 
33, 65]. The challenge becomes daunting when we envisage 
a role of SGV in shaping our neurons to produce just one 
brain (ours) out of the many possible ones which our inher-
ited genome could have borne out by interacting with its 
unarguably changing environments: “If correct, this hy-
pothesis predicts that individual neural cells will, in fact, 
have distinctive spatially and temporally defined genomic 
sequences and chromatin structure.” [66]. Nothing new un-
der the sun: this prediction simply adds more appeal to the 
teachings untiringly dispensed over the years by Temin [12], 
McClintock [15] and Edelman [67], and will perhaps stimu-
late some re-evaluation of the significance of the notion that 
“brain plasticity, while considerable, is constrained by ge-
netics.” [68].  
  The increasing overlapping of the broad fields of genom-
ics and epigenomics emphasizes the importance of a large-
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tions of chromatin (the cellular structure which 140 years 
ago was dubbed “nuclein” by Miescher and launched mo-
lecular genetics), as well as of their phenotypic and behav-
ioural consequences. The size of the endeavours and the ex-
pected value of the results recommend an integrated ap-
proach, but the absence of a rigorously defined listing of the 
variables, combined with the possibility of single groups to 
follow independent lines of research with accessible instru-
mentation would rather encourage the promotion of several 
investigators-driven projects.  
  If the pursuit of God’s particle, under the species of 
Higgs’ boson, as approved and enacted by the scientific 
community, needs a 27-km long, 5 billion , 10.000 re-
searchers LHC at CERN, Geneva, the Holy Grail of human 
genetics, i. e. the deciphering of our phenotype(s) from the 
spelling of the A, C, G and T of our genome(s), does not 
require a similar deployment of investigative weapons. Even 
assuming it can be found at all, it is possible that similarly 
relevant advancements would be secured thanks to less struc-
tured small scale studies, with minor overall risks if some-
thing goes out of control, experimentally as well as concep-
tually. 
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